INTRODUCTIONExcipients are defined as inert substances added to a drug or food to confer a suitable consistency, appearance, or form. They may be added for bulk, to change dissolution or…

INTRODUCTIONA frail 93-year-old woman with multiple medical problems presented with a biopsy-proven melanoma in situ involving the entire left lower eyelid, involving the conjunctiva and extending several centimeters into the…

INTRODUCTIONDermatomyositis (DM) is an inflammatory myopathy defined by progressive weakness and classically associated with a heliotrope or violaceous rash, Gottron sign, and periungual erythema.1,2 Juvenile DM presents before the age…

INTRODUCTIONAn 89-year-old man presented with a large basal cell carcinoma tumor on his right retroauricular area adjacent to the mastoid–auricle border (Figure 1). The clinical tumor size was 17 ×…

INTRODUCTIONInhaled corticosteroids are potent and effective drugs used to treat moderate or mild persistent asthma. The most common adverse drug reactions (ADRs) related to the use of inhaled corticosteroids include…

BACKGROUNDNonmelanoma skin cancers occur frequently on the ear. After tumor clearance has been confirmed, a number of reconstructive options are available to the dermatologic surgeon, depending on the size, depth,…

The Division of Dermatology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) was created in 1955. Since its inception, it has been a…

DISCLOSURESThe authors have disclosed no relevant conflicts of interest.AUTHOR CORRESPONDENCEH. Ray Jalian MDhjalian@mednet.ucla.edu

CASE REPORTA 37-year-old man with no significant past medical history presented with a 3-year history of a rash on his right hand that started after he punched someone in the…

Current and Future Trends in Topical AntimicrobialsINTRODUCTIONTopical antibiotics have a variety of dermatologic applications, including acne vulgaris, impetigo,1 and other secondarily infected dermatoses2 such as erythrasma,3 furunculosis,2,3 burns,4 and the…

FDA Approves Generic Betamethasone Valerate Foam 0.12% Perrigo Company has announced that its partner, Cobrek Pharmaceuticals, has received FDA approval of an Abbreviated New Drug Application for betamethasone valerate foam…

AGINGA Phase 2 Bilateral (Split-Face) Comparison Study to Assess 2 Formulations of ELAPR Compared to Juvéderm Sponsored by Elastagen Pty Ltd, the purpose of this study is to recruit patients…